Advertisement

A clinical prescription for heart health in midlife women

  • Chrisandra Shufelt
    Correspondence
    Corresponding author at: Barbra Streisand Women’s Heart Center, Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, 8631 W. Third Street, Suite 740 East, Los Angeles, CA 90048, USA.
    Affiliations
    Barbra Streisand Women’s Heart Center, Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    Search for articles by this author
  • Erika Dutra
    Affiliations
    Barbra Streisand Women’s Heart Center, Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    Search for articles by this author
  • Tina Torbati
    Affiliations
    Barbra Streisand Women’s Heart Center, Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    Search for articles by this author
  • Tina Ramineni
    Affiliations
    Barbra Streisand Women’s Heart Center, Cedars-Sinai Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA
    Search for articles by this author

      Highlights

      • Cardiovascular disease is the leading cause of death in women throughout the United States and Europe.
      • Midlife provides an opportunity for healthcare providers to provide education and counseling about healthy lifestyle changes.
      • Novel CVD risk factors include adverse pregnancy outcomes, autoimmune diseases, depression, and cancer treatments.

      Abstract

      Cardiovascular disease is the leading cause of death in women throughout the United States and Europe. Despite efforts to raise awareness, the sex-specific risk factors are still poorly recognized in both regions, and many women do not identify cardiovascular disease as a primary threat. During midlife, the incidence of cardiovascular disease increases dramatically, and this unique time gives an opportunity to identify both traditional cardiovascular risk factors as well as emerging risk factors unique to women. This review will focus on the current guidelines for cardiovascular risk assessment in Europe and the United States, traditional and emerging cardiovascular risk factors, and preventive lifestyle recommendations for midlife women.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • MEMBERS W.G.
        • Benjamin E.J.
        • Blaha M.J.
        • et al.
        Heart disease and stroke statistics—2017 update: a report from the American Heart Association.
        Circulation. 2017; 135: e146
        • Siegel R.L.
        • Miller K.D.
        • Jemal A.
        Cancer statistics, 2017.
        CA Cancer J. Clin. 2017; 67: 7-30
        • Mosca L.
        • Jones W.K.
        • King K.B.
        • Ouyang P.
        • Redberg R.F.
        • Hill M.N.
        Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States.
        Arch. Fam. Med. 2000; 9: 506
        • Conroy R.
        • Pyörälä K.
        • Ae Fitzgerald
        • et al.
        Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.
        Eur. Heart J. 2003; 24: 987-1003
        • Goff D.C.
        • Lloyd-Jones D.M.
        • Bennett G.
        • et al.
        2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J. Am. Coll. Cardiol. 2014; 63: 2935-2959
        • Semb A.G.
        • Rollefstad S.
        • Van Riel P.
        • Kitas G.D.
        • Matteson E.L.
        • Gabriel S.E.
        Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice.
        Ann. Rheum. Dis. 2014; (annrheumdis-2013-204792)
        • Stramba-Badiale M.
        • Fox K.M.
        • Priori S.G.
        • et al.
        Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology.
        Eur. Heart J. 2006; 27: 994-1005
        • Peters S.A.
        • Huxley R.R.
        • Woodward M.
        Comparison of the sex-specific associations between systolic blood pressure and the risk of cardiovascular disease: a systematic review and meta-analysis of 124 cohort studies, including 1.2 million individuals.
        Stroke. 2013; 44: 2394-2401
        • Coylewright M.
        • Reckelhoff J.F.
        • Ouyang P.
        Menopause and hypertension: an age-old debate.
        Hypertension. 2008; 51: 952-959
        • Pimenta E.
        Hypertension in women.
        Hypertens. Res. 2012; 35: 148
        • Colafella K.M.M.
        • Denton K.M.
        Sex-specific differences in hypertension and associated cardiovascular disease.
        Nat. Rev. Nephrol. 2018; 14: 185
        • Ong K.L.
        • Tso A.W.
        • Lam K.S.
        • Cheung B.M.
        Gender difference in blood pressure control and cardiovascular risk factors in Americans with diagnosed hypertension.
        Hypertension. 2008; 51: 1142-1148
        • Reckelhoff J.F.
        Gender differences in the regulation of blood pressure.
        Hypertension. 2001; 37: 1199-1208
        • Maric-Bilkan C.
        • Manigrasso M.B.
        Sex differences in hypertension: contribution of the renin–angiotensin system.
        Gend. Med. 2012; 9: 287-291
        • Krishnamurthi K.
        • Verbalis J.G.
        • Zheng W.
        • Wu Z.
        • Clerch L.B.
        • Sandberg K.
        Estrogen regulates angiotensin AT1 receptor expression via cytosolic proteins that bind to the 5′ leader sequence of the receptor mRNA.
        Endocrinology. 1999; 140: 5435-5438
        • Gallagher P.E.
        • Li P.
        • Lenhart J.R.
        • Chappell M.C.
        • Brosnihan K.B.
        Estrogen regulation of angiotensin-converting enzyme mRNA.
        Hypertension. 1999; 33: 323-328
        • Harrison-Bernard L.M.
        • Schulman I.H.
        • Raij L.
        Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity.
        Hypertension. 2003; 42: 1157-1163
        • Swica Y.
        • Warren M.P.
        • Manson J.E.
        • et al.
        Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women’s Health Initiative hormone therapy trials.
        Menopause. 2018; 25: 753-761
        • Williams B.
        • Mancia G.
        • Spiering W.
        • et al.
        2018 ESC/ESH Guidelines for the management of arterial hypertension.
        Eur. Heart J. 2018;
        • Whelton P.K.
        • Carey R.M.
        • Aronow W.S.
        • et al.
        ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
        J. Am. Coll. Cardiol. 2017; 71 (2018): e127-e248
        • Chobanian A.V.
        • Bakris G.L.
        • Black H.R.
        • et al.
        The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report.
        JAMA. 2003; 289: 2560-2571
        • Group S.R.
        A randomized trial of intensive versus standard blood-pressure control.
        N. Engl. J. Med. 2015; 373: 2103-2116
        • Williamson J.D.
        • Supiano M.A.
        • Applegate W.B.
        • et al.
        Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged≥ 75 years: a randomized clinical trial.
        Jama. 2016; 315: 2673-2682
        • Fatima Y.
        A comparative study of serum estrogen and lipid profile in pre-menopausal and post-menopausal women as atherosclerotic risk factors.
        Int. J. Clin. Biochem. Res. 2017; 4: 237-241
        • Deepti G.
        • Shetty S.
        • Rao A.V.
        • Ahmad S.
        Age related difference in the lipid profile in normal healthy women.
        Nitte Univ. J. Health Sci. 2014; 4: 94
        • de Kat A.
        • Dam V.
        • Onland-Moret N.
        • Eijkemans M.
        • Broekmans F.
        • van der Schouw Y.
        Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study.
        BMC Med. 2017; 15: 2
        • Woodard G.A.
        • Brooks M.M.
        • Barinas-Mitchell E.
        • Mackey R.H.
        • Matthews K.A.
        • Sutton-Tyrrell K.
        Lipids, menopause, and early atherosclerosis in Study of Women’s Health Across the Nation Heart women.
        Menopause. 2011; 18: 376-384
        • Wang N.
        • Qin M.Z.
        • Cui J.
        Lipid profile comparison between pre- and post-menopausal women.
        Zhonghua Xin Xue Guan Bing Za Zhi. 2016; 44: 799-804
        • Catapano A.L.
        • Graham I.
        • De Backer G.
        • et al.
        ESC/EAS guidelines for the management of dyslipidaemias the task force for the management of dyslipidaemias of the european society of cardiology (ESC) and european atherosclerosis society (EAS) developed with the special contribution of the european assocciation for cardiovascular prevention & rehabilitation (EACPR).
        Atherosclerosis. 2016;
        • Walldius G.
        • Jungner I.
        • Holme I.
        • Aastveit A.H.
        • Kolar W.
        • Steiner E.
        High apolipoprotein B, low apolipoprotein AI, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
        Lancet. 2001; 358: 2026-2033
        • Meisinger C.
        • Loewel H.
        • Mraz W.
        • Koenig W.
        Prognostic value of apolipoprotein B and AI in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
        Eur. Heart J. 2004; 26: 271-278
        • Sniderman A.
        • Furberg C.
        • Keech A.
        • et al.
        Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.
        Lancet. 2003; 361: 777-780
        • Stone N.J.
        • Robinson J.G.
        • Lichtenstein A.H.
        • et al.
        2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J. Am. Coll. Cardiol. 2014; 63: 2889-2934
        • Tamayo T.
        • Rosenbauer J.
        • Wild S.
        • et al.
        Diabetes in Europe: an update.
        Diabetes Res. Clin. Pract. 2014; 103: 206-217
        • Ogurtsova K.
        • da Rocha Fernandes J.
        • Huang Y.
        • et al.
        IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040.
        Diabetes Res. Clin. Pract. 2017; 128: 40-50
      1. Control CfD, Prevention. Diabetes and Women’s Health Across the Life Stages: a Public Health Perspective.
        US Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA2001
        • Kim C.
        Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women.
        Women’s Health. 2012; 8: 155-167
        • Folta S.C.
        • Lichtenstein A.H.
        • Seguin R.A.
        • Goldberg J.P.
        • Kuder J.F.
        • Nelson M.E.
        The StrongWomen–healthy Hearts program: reducing cardiovascular disease risk factors in rural sedentary, overweight, and obese midlife and older women.
        Am. J. Public Health. 2009; 99: 1271-1277
        • Colditz G.A.
        • Willett W.C.
        • Rotnitzky A.
        • Manson J.E.
        Weight gain as a risk factor for clinical diabetes mellitus in women.
        Ann. Intern. Med. 1995; 122: 481-486
        • Wilkins E.
        • Wilson L.
        • Wickramasinghe K.
        • et al.
        European Cardiovascular Disease Statistics 2017.
        2017
        • PAN W.-H.
        • Cedres L.B.
        • Liu K.
        • et al.
        Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women.
        Am. J. Epidemiol. 1986; 123: 504-516
        • Abbott R.D.
        • Donahue R.P.
        • Kannel W.B.
        • Wilson P.W.
        The impact of diabetes on survival following myocardial infarction in men vs women: the Framingham Study.
        Jama. 1988; 260: 3456-3460
        • Huxley R.
        • Barzi F.
        • Woodward M.
        Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.
        Bmj. 2006; 332: 73-78
        • Everson-Rose S.A.
        • Meyer P.M.
        • Powell L.H.
        • et al.
        Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife.
        Diabetes Care. 2004; 27: 2856-2862
        • Penno G.
        • Solini A.
        • Bonora E.
        • et al.
        Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study.
        J. Intern. Med. 2013; 274: 176-191
        • Booth G.L.
        • Kapral M.K.
        • Fung K.
        • Tu J.V.
        Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study.
        Lancet. 2006; 368: 29-36
        • Members A.T.F.
        • Rydén L.
        • Grant P.J.
        • et al.
        ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
        Eur. Heart J. 2013; 34: 3035-3087
        • Organization W.H.
        Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus.
        World health organization, Geneva1999
      2. Association AD. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018.
        Diabetes Care. 2018; 41: S13-S27
        • Lindström J.
        • Tuomilehto J.
        The diabetes risk score: a practical tool to predict type 2 diabetes risk.
        Diabetes Care. 2003; 26: 725-731
        • Saaristo T.
        • Peltonen M.
        • Lindström J.
        • et al.
        Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome.
        Diab. Vasc. Dis. Res. 2005; 2: 67-72
        • Piepoli M.F.
        • Hoes A.W.
        • Agewall S.
        • et al.
        2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).
        Eur. Heart J. 2016; 37: 2315-2381
        • Leander K.
        • Hallqvist J.
        • Reuterwall C.
        • Ahlbom A.
        • de Faire U.
        Family history of coronary heart disease, a strong risk factor for myocardial infarction interacting with other cardiovascular risk factors: results from the Stockholm Heart Epidemiology Program (SHEEP).
        Epidemiology. 2001; : 215-221
        • Organization W.H.
        WHO Report on the Global Tobacco Epidemic, 2017: Monitoring Tobacco Use and Prevention Policies.
        2017
        • Prescott E.
        • Hippe M.
        • Schnohr P.
        • Hein H.O.
        • Vestbo J.
        Smoking and risk of myocardial infarction in women and men: longitudinal population study.
        Bmj. 1998; 316: 1043
        • Baron J.A.
        • La Vecchia C.
        • Levi F.
        The antiestrogenic effect of cigarette smoking in women.
        Am. J. Obstet. Gynecol. 1990; 162: 502-514
        • Mikkelsen T.F.
        • Graff-Iversen S.
        • Sundby J.
        • Bjertness E.
        Early menopause, association with tobacco smoking, coffee consumption and other lifestyle factors: a cross-sectional study.
        BMC Public Health. 2007; 7: 149
        • Grana R.A.
        • Popova L.
        • Ling P.M.
        A longitudinal analysis of electronic cigarette use and smoking cessation.
        JAMA Intern. Med. 2014; 174: 812-813
        • Hom S.
        • Wang T.
        • Chen L.
        • Yin W.
        • Rubenstein D.A.
        Electronic cigarettes modulate platelet inflammatory, adhesion, activation and aggregation responses.
        Faseb J. 2016; 30 (722.725-722.725)
        • Shah B.R.
        • Retnakaran R.
        • Booth G.L.
        Increased risk of cardiovascular disease in young women following gestational diabetes mellitus.
        Diabetes Care. 2008; 31: 1668-1669
        • Bellamy L.
        • Casas J.-P.
        • Hingorani A.D.
        • Williams D.J.
        Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.
        Bmj. 2007; 335: 974
        • Lykke J.A.
        • Langhoff-Roos J.
        • Sibai B.M.
        • Funai E.F.
        • Triche E.W.
        • Paidas M.J.
        Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother.
        Hypertension. 2009; 53: 944-951
        • Wilson B.J.
        • Watson M.S.
        • Prescott G.J.
        • et al.
        Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study.
        Bmj. 2003; 326: 845
        • Carr D.B.
        • Utzschneider K.M.
        • Hull R.L.
        • et al.
        Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes.
        Diabetes Care. 2006; 29: 2078-2083
        • Sattar N.
        • Greer I.A.
        Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?.
        Bmj. 2002; 325: 157-160
        • Hansson G.K.
        Inflammation, atherosclerosis, and coronary artery disease.
        N. Engl. J. Med. 2005; 352: 1685-1695
        • Ridker P.M.
        Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity.
        Nutr. Rev. 2007; 65: S253-S259
        • Yeboah J.
        • Young R.
        • McClelland R.L.
        • et al.
        Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment.
        J. Am. Coll. Cardiol. 2016; 67: 139-147
        • Khera A.
        • McGuire D.K.
        • Murphy S.A.
        • et al.
        Race and gender differences in C-reactive protein levels.
        J. Am. Coll. Cardiol. 2005; 46: 464-469
        • Maradit-Kremers H.
        • Crowson C.S.
        • Nicola P.J.
        • et al.
        Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population‐based cohort study.
        Arthritis Rheum. 2005; 52: 402-411
        • Warrington K.J.
        • Kent P.D.
        • Frye R.L.
        • et al.
        Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study.
        Arthritis Res. Ther. 2005; 7: R984
        • Ludwig R.J.
        • Herzog C.
        • Rostock A.
        • et al.
        Psoriasis: a possible risk factor for development of coronary artery calcification.
        Br. J. Dermatol. 2007; 156: 271-276
        • Hermansen M.-L.
        • Lindhardsen J.
        • Torp-Pedersen C.
        • Faurschou M.
        • Jacobsen S.
        The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.
        Rheumatology. 2017; 56: 709-715
        • Rho Y.H.
        • Oeser A.
        • Chung C.P.
        • Milne G.L.
        • Stein C.M.
        Drugs used in the treatment of rheumatoid arthritis: relationship between current use and cardiovascular risk factors.
        Arch. Drug Inf. 2009; 2: 34-40
        • Mason J.C.
        • Libby P.
        Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.
        Eur. Heart J. 2014; 36: 482-489
        • Arts E.
        • Popa C.
        • Den Broeder A.
        • et al.
        Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
        Ann. Rheum. Dis. 2014; (annrheumdis-2013-204024)
        • Agca R.
        • Heslinga S.
        • Rollefstad S.
        • et al.
        EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
        Ann. Rheum. Dis. 2017; 76: 17-28
        • Joynt K.E.
        • Whellan D.J.
        • O’Connor C.M.
        Depression and cardiovascular disease: mechanisms of interaction.
        Biol. Psychiatry. 2003; 54: 248-261
        • Freeman E.W.
        • Sammel M.D.
        • Lin H.
        • Nelson D.B.
        Associations of hormones and menopausal status with depressed mood in women with no history of depression.
        Arch. Gen. Psychiatry. 2006; 63: 375-382
        • Bromberger J.
        • Schott L.
        • Kravitz H.
        • Joffe H.
        Risk factors for major depression during midlife among a community sample of women with and without prior major depression: are they the same or different?.
        Psychol. Med. 2015; 45: 1653-1664
        • Avis N.E.
        • Brambilla D.
        • McKinlay S.M.
        • Vass K.
        A longitudinal analysis of the association between menopause and depression Results from the Massachusetts women’s health study.
        Ann. Epidemiol. 1994; 4: 214-220
        • McKinlay J.B.
        • McKinlay S.M.
        • Brambilla D.
        The relative contributions of endocrine changes and social circumstances to depression in mid-aged women.
        J. Health Soc. Behav. 1987; : 345-363
        • Graziottin A.
        • Serafini A.
        Depression and the menopause: why antidepressants are not enough?.
        Menopause Int. 2009; 15: 76-81
        • Cohen L.S.
        • Soares C.N.
        • Vitonis A.F.
        • Otto M.W.
        • Harlow B.L.
        Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles.
        Arch. Gen. Psychiatry. 2006; 63: 385-390
        • Hare D.L.
        • Toukhsati S.R.
        • Johansson P.
        • Jaarsma T.
        Depression and cardiovascular disease: a clinical review.
        Eur. Heart J. 2013; 35: 1365-1372
        • Van der Kooy K.
        • Van Hout H.
        • Marwijk H.
        • Marten H.
        • Stehouwer C.
        • Beekman A.
        Depression and the risk for cardiovascular diseases: systematic review and meta analysis.
        Int. J. Geriatr. Psychiatry. 2007; 22: 613-626
        • Bush D.E.
        • Ziegelstein R.C.
        • Tayback M.
        • et al.
        Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.
        Am. J. Cardiol. 2001; 88: 337-341
        • Lichtman J.H.
        • Bigger Jr, J.T.
        • Blumenthal J.A.
        • et al.
        Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association.
        Circulation. 2008; 118: 1768-1775
        • Suter T.M.
        • Procter M.
        • van Veldhuisen D.J.
        • et al.
        Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
        J. Clin. Oncol. 2007; 25: 3859-3865
        • Curigliano G.
        • Cardinale D.
        • Suter T.
        • et al.
        Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.
        Ann. Oncol. 2012; 23: vii155-vii166
        • Heidenreich P.A.
        • Kapoor J.R.
        Radiation induced heart disease.
        Heart. 2009; 95: 252-258
        • Brosius I.I.I.F.C.
        • Waller B.F.
        • Roberts W.C.
        Radiation heart disease: analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart.
        Am. J. Med. 1981; 70: 519-530
        • Darby S.C.
        • Cutter D.J.
        • Boerma M.
        • et al.
        Radiation-related heart disease: current knowledge and future prospects.
        Int. J. Radiat. Oncol. Biol. Phys. 2010; 76: 656-665
        • Adams M.J.
        • Hardenbergh P.H.
        • Constine L.S.
        • Lipshultz S.E.
        Radiation-associated cardiovascular disease.
        Crit. Rev. Oncol. Hematol. 2003; 45: 55-75
        • Jones A.
        • Barlow M.
        • Barrett-Lee P.
        • et al.
        Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer research Institute recommendations for monitoring.
        Br. J. Cancer. 2009; 100: 684
        • Eschenhagen T.
        • Force T.
        • Ewer M.S.
        • et al.
        Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology.
        Eur. J. Heart Fail. 2011; 13: 1-10
        • Mehta L.S.
        • Watson K.E.
        • Barac A.
        • et al.
        Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association.
        Circulation. 2018; (CIR. 0000000000000556)
        • Buttar H.S.
        • Li T.
        • Ravi N.
        Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation.
        Exp. Clin. Cardiol. 2005; 10: 229
        • Thompson P.D.
        • Buchner D.
        • Piña I.L.
        • et al.
        Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).
        Circulation. 2003; 107: 3109-3116
        • Mishra N.
        • Mishra V.N.
        D. Exercise beyond menopause: dos and don’ts.
        J. Midlife Health. 2011; 2: 51
        • Cramer H.
        • Lauche R.
        • Haller H.
        • Steckhan N.
        • Michalsen A.
        • Dobos G.
        Effects of yoga on cardiovascular disease risk factors: a systematic review and meta-analysis.
        Int. J. Cardiol. 2014; 173: 170-183
        • Eckel R.H.
        • Jakicic J.M.
        • Ard J.D.
        • et al.
        2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
        J. Am. Coll. Cardiol. 2014; 63: 2960-2984
        • Mosca L.
        • Benjamin E.J.
        • Berra K.
        • et al.
        Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association.
        J. Am. Coll. Cardiol. 2011; 57: 1404-1423
        • Shaw L.J.
        • Merz C.N.B.
        • Pepine C.J.
        • et al.
        Insights from the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.
        J. Am. Coll. Cardiol. 2006; 47: S4-S20
        • Jamal A.
        Current Cigarette Smoking Among Adults—United States, 2005–2015. MMWR Morbidity and Mortality Weekly Report..
        2016 (65)
        • UDo Health
        • Services H.
        The Health Consequences of Smoking: a Report of the Surgeon General.
        2004
        • Kawachi I.
        • Colditz G.A.
        • Stampfer J.
        • et al.
        Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women.
        Arch. Intern. Med. 1994; 154: 169-175
        • Bush T.
        • Hsu C.
        • Levine M.D.
        • Magnusson B.
        • Miles L.
        Weight gain and smoking: perceptions and experiences of obese quitline participants.
        BMC Public Health. 2014; 14: 1229
        • McHugh R.K.
        • Hearon B.A.
        • Otto M.W.
        Cognitive behavioral therapy for substance use disorders.
        Psychiatr. Clin. 2010; 33: 511-525
        • Stead L.F.
        • Perera R.
        • Bullen C.
        • et al.
        Nicotine replacement therapy for smoking cessation.
        Cochrane Database Syst. Rev. 2012; 11
        • Gray K.M.
        • McClure E.A.
        • Baker N.L.
        • Hartwell K.J.
        • Carpenter M.J.
        • Saladin M.E.
        An exploratory short‐term double‐blind randomized trial of varenicline versus nicotine patch for smoking cessation in women.
        Addiction. 2015; 110: 1027-1034
        • Fava M.
        • Rush A.J.
        • Thase M.E.
        • et al.
        15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL.
        Primary Care Comp. J. Clin. Psychiatry. 2005; 7: 106
        • Chivers L.L.
        • Hand D.J.
        • Priest J.S.
        • Higgins S.T.
        E-cigarette use among women of reproductive age: impulsivity, cigarette smoking status, and other risk factors.
        Prev. Med. 2016; 92: 126-134
        • Ronksley P.E.
        • Brien S.E.
        • Turner B.J.
        • Mukamal K.J.
        • Ghali W.A.
        Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis.
        Bmj. 2011; 342: d671
        • Heffernan T.M.
        The impact of excessive alcohol use on prospective memory: a brief review.
        Curr. Drug Abuse Rev. 2008; 1: 36-41
        • Xin X.
        • He J.
        • Frontini M.G.
        • Ogden L.G.
        • Motsamai O.I.
        • Whelton P.K.
        Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials.
        Hypertension. 2001; 38: 1112-1117
        • Reynolds K.
        • Lewis B.
        • Nolen J.D.L.
        • Kinney G.L.
        • Sathya B.
        • He J.
        Alcohol consumption and risk of stroke: a meta-analysis.
        JAMA. 2003; 289: 579-588
        • Pompili M.
        • Serafini G.
        • Innamorati M.
        • et al.
        Suicidal behavior and alcohol abuse.
        Int. J. Environ. Res. Public Health. 2010; 7: 1392-1431
        • Sun Q.
        • Townsend M.K.
        • Okereke O.I.
        • et al.
        Alcohol consumption at midlife and successful ageing in women: a prospective cohort analysis in the nurses’ health study.
        PLoS Med. 2011; 8e1001090
        • Carr M.C.
        The emergence of the metabolic syndrome with menopause.
        J. Clin. Endocrinol. Metab. 2003; 88: 2404-2411
        • Kenchaiah S.
        • Evans J.C.
        • Levy D.
        • et al.
        Obesity and the risk of heart failure.
        N. Engl. J. Med. 2002; 347: 305-313
        • Kim S.H.
        • Després J.-P.
        • Koh K.K.
        Obesity and cardiovascular disease: friend or foe?.
        Eur. Heart J. 2015; 37: 3560-3568
        • Sternfeld B.
        • Dugan S.
        Physical activity and health during the menopausal transition.
        Obstet. Gynecol. Clin. North Am. 2011; 38: 537-566
        • Townsend N.
        • Wilson L.
        • Bhatnagar P.
        • Wickramasinghe K.
        • Rayner M.
        • Nichols M.
        Cardiovascular disease in Europe: epidemiological update 2016.
        Eur. Heart J. 2016; 37: 3232-3245
        • Janssen I.
        • Powell L.H.
        • Crawford S.
        • Lasley B.
        • Sutton-Tyrrell K.
        Menopause and the metabolic syndrome: the study of women’s health across the nation.
        Arch. Intern. Med. 2008; 168: 1568-1575